OKYO Pharma Limited Receivables

OKYO Pharma Limited (OKYO) currently reports a receivables of $170K as of March 2026. That compares with $1.9M in the prior-year period — down 91.0% year over year. Use the charts on this page to explore OKYO Pharma Limited's receivables history and peer comparisons.

OKYO Pharma Limited's receivables decreased from $1.9M to $170K — a 91.0% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

OKYO Pharma Limited reported $170K in receivables as of March 2026. That compares with $1.9M in the prior-year period — down 91.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $170K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for OKYO Pharma Limited, and consider following OKYO for alerts when major investors trade the stock.

OKYO Pharma Limited is classified in the Healthcare sector. On receivables, it currently shows $170K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OKYO with unrelated industries.